• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白依赖性激酶 5/ p25 抑制剂的对接和 3D-QSAR 建模。

Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitors.

机构信息

Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.

出版信息

J Mol Model. 2011 May;17(5):1149-61. doi: 10.1007/s00894-010-0817-2. Epub 2010 Aug 5.

DOI:10.1007/s00894-010-0817-2
PMID:20686908
Abstract

Structure-based 3D-QSAR approaches (CoMFA and CoMSIA) were applied to understand the structural requirements of the Cyclin-dependent kinase 5/p25 inhibitors. Cyclin-dependent kinase 5 (CDK5) is believed to play an important role in the development of the central nervous system during the process of mammalian embryogenesis. Genetic algorithm based docking program (GOLD) was successfully utilized to orient the compounds inside the binding pocket of the CDK5/p25 structure. The adapted alignment method with the suitable parameters resulted in a reliable model. Furthermore, the final model was robust enough to forecast the activities of test compounds, satisfactorily. The contour maps were produced around the functional groups to understand the SAR requirements. Moreover, we also investigate the structural attributes of the inhibitors which make them selective toward CDK5/p25 over its close counterpart, i.e., CDK2. The study could be helpful to rationalize the new compounds with better inhibition and selectivity profiles against CDK5/p25.

摘要

基于结构的 3D-QSAR 方法(CoMFA 和 CoMSIA)被应用于理解细胞周期蛋白依赖性激酶 5/p25 抑制剂的结构要求。细胞周期蛋白依赖性激酶 5(CDK5)被认为在哺乳动物胚胎发生过程中中枢神经系统的发育中起着重要作用。基于遗传算法的对接程序(GOLD)成功地用于将化合物定向到 CDK5/p25 结构的结合口袋内。经过适当参数调整的适配对齐方法产生了可靠的模型。此外,最终模型足够稳健,可以令人满意地预测测试化合物的活性。在功能基团周围生成了等高线图,以了解 SAR 要求。此外,我们还研究了抑制剂的结构属性,这些属性使它们对 CDK5/p25 具有选择性,而不是对其密切对应的 CDK2。这项研究有助于合理化新化合物,使其对 CDK5/p25 具有更好的抑制和选择性。

相似文献

1
Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitors.细胞周期蛋白依赖性激酶 5/ p25 抑制剂的对接和 3D-QSAR 建模。
J Mol Model. 2011 May;17(5):1149-61. doi: 10.1007/s00894-010-0817-2. Epub 2010 Aug 5.
2
Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.采用 3D-QSAR 和对接技术对 4,5-二氢-1H-吡唑并[4,3-h]喹唑啉衍生物作为潜在的 CDK2/细胞周期蛋白 A 抑制剂的分子建模研究。
Int J Mol Sci. 2010 Sep 28;11(10):3705-24. doi: 10.3390/ijms11103705.
3
Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.通过三维定量构效关系(3D-QSAR)和分子动力学模拟对N-苯基嘧啶-2-胺对细胞周期蛋白依赖性激酶2(CDK2)和细胞周期蛋白依赖性激酶4(CDK4)的选择性进行表征的分子建模研究。
Mol Biosyst. 2016 Apr;12(4):1250-68. doi: 10.1039/c5mb00860c. Epub 2016 Feb 17.
4
Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.通过基于结构的虚拟筛选发现噻吩并喹诺酮衍生物作为选择性和ATP非竞争性CDK5/p25抑制剂
Bioorg Med Chem. 2014 Nov 15;22(22):6409-21. doi: 10.1016/j.bmc.2014.09.043. Epub 2014 Sep 28.
5
Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors.嘌呤衍生物作为新型 CDK2 抑制剂的分子建模与设计研究。
Molecules. 2018 Nov 9;23(11):2924. doi: 10.3390/molecules23112924.
6
Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.CDK5/p25和CDK2/细胞周期蛋白A动力学揭示的CDK5和CDK2激活的不同机制
J Biol Chem. 2006 Mar 17;281(11):7271-81. doi: 10.1074/jbc.M509699200. Epub 2006 Jan 9.
7
Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.环丁基取代咪唑抑制剂对 CDK 选择性差异的分子基础:对合理药物设计的启示。
PLoS One. 2013 Sep 13;8(9):e73836. doi: 10.1371/journal.pone.0073836. eCollection 2013.
8
3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.作为细胞周期蛋白依赖性激酶2抑制剂的苯并二吡唑类化合物的3D-QSAR CoMFA和CoMSIA研究
Med Chem. 2008 Jul;4(4):313-21. doi: 10.2174/157340608784872244.
9
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的高效且具有细胞活性的细胞周期蛋白依赖性激酶5/p25的4-氨基咪唑抑制剂
Bioorg Med Chem Lett. 2009 Oct 1;19(19):5703-7. doi: 10.1016/j.bmcl.2009.08.019. Epub 2009 Aug 8.
10
Cyclin-dependent kinases 5 template: useful for virtual screening.细胞周期蛋白依赖性激酶 5 模板:可用于虚拟筛选。
Comput Biol Med. 2012 Jan;42(1):106-11. doi: 10.1016/j.compbiomed.2011.10.014. Epub 2011 Nov 12.

引用本文的文献

1
Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.通过基于结构的虚拟筛选发现噻吩并喹诺酮衍生物作为选择性和ATP非竞争性CDK5/p25抑制剂
Bioorg Med Chem. 2014 Nov 15;22(22):6409-21. doi: 10.1016/j.bmc.2014.09.043. Epub 2014 Sep 28.
2
3D-QSPR method of computational technique applied on red reactive dyes by using CoMFA strategy.采用CoMFA策略将计算技术的3D-QSPR方法应用于红色活性染料。
Int J Mol Sci. 2011;12(12):8862-77. doi: 10.3390/ijms12128862. Epub 2011 Dec 5.

本文引用的文献

1
Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site.针对一组靶标进行噬菌体展示筛选以建立基于肽的糖模拟物,并进行分子对接以预测结合位点。
Bioorg Med Chem. 2009 Jul 1;17(13):4825-32. doi: 10.1016/j.bmc.2009.03.054. Epub 2009 Apr 1.
2
Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines.通过比较分子场分析法(CoMFA)和比较分子相似性指数分析法(CoMSIA)对吖啶衍生物进行结构研究,揭示了它们针对DNA G-四链体介导的端粒酶抑制作用的结构新见解,并为取代吖啶提供了一个高度预测性的三维模型。
J Chem Inf Model. 2009 May;49(5):1298-311. doi: 10.1021/ci900036w.
3
Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm.基于受体的建模与三维定量构效关系研究:基于遗传算法定量生成丁酰胆碱酯酶抑制剂
J Chem Inf Model. 2008 May;48(5):1092-103. doi: 10.1021/ci8000056. Epub 2008 Apr 29.
4
New approaches to the discovery of cdk5 inhibitors.发现细胞周期蛋白依赖性激酶5抑制剂的新方法。
Curr Alzheimer Res. 2007 Dec;4(5):547-9. doi: 10.2174/156720507783018181.
5
A novel approach to cyclin-dependent kinase 5/p25 inhibitors: A potential treatment for Alzheimer's disease.一种针对细胞周期蛋白依赖性激酶5/p25抑制剂的新方法:阿尔茨海默病的潜在治疗手段。
Bioorg Med Chem. 2007 Oct 1;15(19):6397-406. doi: 10.1016/j.bmc.2007.06.053. Epub 2007 Jul 4.
6
Predicting anti-HIV activity of PETT derivatives: CoMFA approach.预测PETT衍生物的抗HIV活性:比较分子场分析法
Bioorg Med Chem Lett. 2007 Apr 15;17(8):2197-202. doi: 10.1016/j.bmcl.2007.01.103. Epub 2007 Feb 4.
7
3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.基于分子对接分数和比较分子场分析的乙酰胆碱酯酶抑制剂的3D定量构效关系研究
Bioorg Med Chem Lett. 2006 Dec 15;16(24):6277-80. doi: 10.1016/j.bmcl.2006.09.030. Epub 2006 Oct 16.
8
On evaluating molecular-docking methods for pose prediction and enrichment factors.关于评估用于构象预测和富集因子的分子对接方法。
J Chem Inf Model. 2006 Jan-Feb;46(1):401-15. doi: 10.1021/ci0503255.
9
Improving binding mode predictions by docking into protein-specifically adapted potential fields.通过对接至蛋白质特异性适配的势场来改进结合模式预测。
J Med Chem. 2005 Aug 25;48(17):5466-79. doi: 10.1021/jm050114r.
10
Mechanism of CDK5/p25 binding by CDK inhibitors.CDK抑制剂与CDK5/p25结合的机制。
J Med Chem. 2005 Feb 10;48(3):671-9. doi: 10.1021/jm049323m.